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Abstract There is a considerable variation in the histo-
logic subtype of epithelial malignancies among carcinoma
ex pleomorphic adenomas (CXPA) and virtually any
known carcinoma entity can develop. To our knowledge,
adenoid cystic carcinoma (AdCC) ex PA is quite rare
despite the fact that de novo AdCC is the fourth most
common salivary gland malignancy. We describe a new
case of AdCC ex PA in the parotid gland of a 62 year-old
woman. In our patient, there was a short interval of time
between parotidectomy and local recurrence and rapid
development of distant metastases. Although most of the
reported cases are considered low-grade, evidence is pre-
sented here that AdCC can take the form of a high-grade
malignancy in PA.
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Introduction
Carcinoma ex pleomorphic adenoma (CXPA), as a group,
constitutes 12% of malignant salivary gland tumors [1],
and in data from the Armed Forces Institute of Pathology,
this ranks it as the sixth most common carcinoma at this
location [2]. Of all PA, CXPA accounts for 9.5% [2], and
has been noted ab initio or at recurrence [1–3]. Although
there is no prototypical carcinoma entity, the forms of
malignancy found are most common adenocarcinoma not
other wise speciﬁed, salivary duct carcinoma and undif-
ferentiated carcinoma [1–7]. The malignant component is
often difﬁcult to subclassify as one of exactly deﬁned
carcinoma categories [6], and more than one phenotype
may be present [5, 8].
In previous large series [5–12], the cribriform growth
pattern considered supportive of a diagnosis of adenoid
cystic carcinoma (AdCC) was observed in 4–33% of
CXPA, many of which comprised only a limited portion of
poorly differentiated adenocarcinoma [5, 11]. Of six
reports, four lacked illustrations of the AdCC component
[5–7, 12], and only two involved histopathologic ﬁndings
of AdCC ex PA with no information of the individual case
[8, 11]. In the study of Moberger and Eneroth [10], a single
convincing example was detailed and the same case was
also brieﬂy described in the paper of Eneroth et al. [9]. Our
literature search disclosed six additional cases of pure
AdCC ex PA described by name [13–17]. The following is
a rare emergence of AdCC from a primary PA in the
parotid gland which pursued an unpredictable aggressive-
ness on behavioral basis.
Case Report
A 62 year-old woman presented with an 8 month history of
a painless mass of the right parotid gland. With magnetic
resonance imaging and computed tomography (Fig. 1), a
well-circumscribed, 4 cm tumor with evidence of calciﬁ-
cation was found in the deep lobe and diagnosed at Stage II
(T3N0M0). She had no clinically detectable tumor in any
other site and her past medical history was non-contribu-
tory. Following the histologic diagnosis of CXPA in the
initial parotidectomy specimen, the deﬁnitive surgery with
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completed one month later. Microscopically, there was
neither residual carcinoma nor positive cervical lymph
node. Nineteen months postoperatively, local recurrence
was noted in the posterior pharyngeal wall and small
metastatic foci in the lung and liver were diagnosed on the
basis of computed tomography and magnetic resonance
imaging. At the patient’s wish, both lesions were not
biopsied and only chemotherapy was carried out at another
institution. Although speciﬁc details of protocols were not
available, she still has evidence of disease two years later.
Macroscopically, the bilobed mass measuring 4 9 4 9
3c m
3 appeared deceptively well-demarcated and on cut
surface, contained a large solid nodule with hemorrhage
and smaller foci with sclerosis. On microscopic examina-
tion, the tumor was found to be not excised with clear
margins (Fig. 2a). It was composed of two strikingly
contrasting types of tumor; lobulated aggregates of AdCC
and densely hyalinized nodules of PA, with the former
constituting[80% of lesion (Fig. 2a, b). The remnants of
PA were recognizable by the bilayered ductal structures in
the desmoplastic, calciﬁed or ossiﬁed stroma (Fig. 2c, d).
Solid and cribriform growth patterns occurred together in
the AdCC component; tumor cell necrosis including com-
edo-type was readily apparent in the former and excessive
basal lamina was characteristically evident in the latter
(Fig. 2e, f). The nuclei of basaloid carcinoma cells were
angular and showed moderate mitotic rate and mild to
moderate atypia (Fig. 2g). In the AdCC areas, neural
invasion was common, but there was no vascular
involvement. Because the solid pattern represented more
than 40% of carcinoma, the AdCC element was categorized
into Grade III [18, 19]. Even in multiple sampling, the
transition between PA and AdCC was difﬁcult to trace
because of hypocellularity and hyalinization of the PA
component. The coexistence of another high-grade carci-
noma or carcinosarcoma was not evident.
Discussion
Among seven cases of AdCC ex PA with sufﬁcient data [10,
13–17], ﬁve tumors arose in association with a primary PA
including a long-standing ([50 years) lesion [13–16],
whereas the remaining two developed as a recurrent tumor at
thesiteofapreviouslyexcisedPA[10,17].Itisacknowledged
that PA and AdCC are composed of variable proportions of
ductal and myoepithelial type cells [19–22]. Considering the
immunohistochemical result that 19% of supervening carci-
noma in CXPA shows the bidirectional line of differentiation
into ductal and myoepithelial cells [21, 23], the sequential
evolution of PA to AdCC may not be surprising. Circum-
stantial evidence also comes from cases of PA showing
AdCC-like phenotypic manifestations [22, 24]. Conversely,
the diagnostic consideration of in situ or intracapsular AdCC
within PA should be given in such tumors [7, 9, 11, 13, 24].
The cribriform nests in PA are usually limited to small areas
and their nuclear features are not hyperchromatic, angular as
in the case of AdCC [20, 22].
Conceptually, salivary tumors that occupy a single gland
and consisted of two distinct types may be categolized as
either synchronous or hybrid [19]. There were only a few
reports on simultaneous occurrence of PA and adenocar-
cinoma; the latter included acinic cell adenocarcinoma,
mucoepidermoid carcinoma and salivary duct carcinoma
only [25]. An unusual combination of myoepithelioma of
spindle cell variant and AdCC of cribriform type was also
described [26]. Importantly, synchronous tumors never
demonstrate a conﬂuence between two separable entities as
seen in CXPA [25]. It is our understanding that hybrid
lesions show transitional areas between two histologically
different tumors in a single mass, suggesting their clonal
origin [27]. This rare condition can be seen as a combi-
nation of hybrid adenomas, hybrid carcinomas or
carcinoma with adenoma [19] and the most commonly
reported partner of AdCC was salivary duct carcinoma and
epithelial-myoepithelial carcinoma [27]. In contrast to
CXPA, hybrid tumors are usually characterized by the
mixture of two well-deﬁned carcinomas [27], and hybrids
exhibiting both benign and malignant components are
Fig. 1 Computed tomography scan shows a heterogeneously
enhanced and well-circumscribed tumor of the right parotid gland
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and AdCC [19].
One of the important pathologic factors associated with
patientprognosisinAdCCincludestumorgrade[18–20,28].
Unfortunately, the universally accepted grading system for
de novo AdCC, i.e., the proportion of the tumor with a solid
pattern, has not yet been used in any case of AdCC ex PA.
Judging from the photomicrographs and/or descriptions,
most of the previously reported cases of AdCC ex PA were
low-grade [6, 8, 11, 13–15, 17]. The present AdCC compo-
nent was regarded as Grade III and the solid growth pattern
was predominant in two remaining cases that developed
metastasis [9, 16]. In de novo AdCC, distant metastasis fre-
quently occurs without regional lymph node involvement,
even after local control of tumor [20, 28]. Given that two of
three cases with metastatic spread had negative cervical
nodes [15, 16], AdCC ex PA is certainly no exception;
notably, two patients represented skin metastasis that isvery
rareindenovoAdCC[9,15].Inthepresenthigh-gradecase,
clinical signs of local recurrences and distant metastases
were evinced within 19 months on follow-up imaging;
nevertheless, our patient is alive with disease two years
postoperatively. This is in keeping with the fact that some of
patients with de novo AdCC pursue prolonged survivals
despite distant metastasis [28].
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